Trial Profile
Gonadotrophin-releasing hormone (GnRH) antagonist degarelix in female patients with polycystic ovary syndrome
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Feb 2013
Price :
$35
*
At a glance
- Drugs Cetrorelix (Primary) ; Degarelix (Primary) ; Follitropin alfa
- Indications Polycystic ovary syndrome
- Focus Therapeutic Use
- 01 Feb 2013 New trial record